We are live on ! Find out more
ISPC icon

iSpecimen

12 hedge funds and large institutions have $597K invested in iSpecimen in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

8% less funds holding

Funds holding: 1312 (-1)

10% less capital invested

Capital invested by funds: $665K → $597K (-$68.5K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ISPC Hedge Fund Activity: Q2 2023 in Review

12 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2023, worth a combined $597K — down 10% from $665K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ISPC and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $33.8K. The largest seller was Bleichroeder LP, exiting entirely with an estimated $88.2K sold.

  • 12 institutional investors held iSpecimen (ISPC) as of Q2 2023, down from 13 in Q1 2023.
  • Funds reported $597K of iSpecimen stock for Q2 2023, down 10% quarter-over-quarter.
  • 2 funds opened new iSpecimen positions in Q2 2023 and 3 closed out, a net change of -1 holder.
  • The largest iSpecimen buyer in Q2 2023 was Citadel Advisors, an estimated $33.8K added.
  • The largest iSpecimen seller in Q2 2023 was Bleichroeder LP, an estimated $88.2K sold.

Based on aggregated 13F filings for Q2 2023.